Van Vollenhoven R, Hahn BH, Tsokos GC, et al. Efficacy and Safety of Ustekinumab, an Interleukin 12/23 Inhibitor, in Patients with Active Systemic Lupus Erythematosus: Results of a Phase 2, Randomized Placebo-Controlled Study. ACR 2017, abstract 6L.
Ernstige bijwerkingen (hydroxy)chloroquine bij malaria en reuma zeldzaam
jan 2024 | Parasitaire infecties, RA, Virale infecties